The difference between the groups increased when evaluated at d 56 (28 d following last dose) at which point the mean improvement in the ARA 290 had increased to 4.2, and the placebo group diminished to 0.74 points
2.2 Experimental animals and design Male and female ICR-CD1 mice aged between 46 weeks and 2535 g, obtained from the Centre for Comparative Medicine Research (CCMR) of the University of Hong Kong, were used in the study
Lipo Mino Mix Injection (MICC ingredients plus B1, B2, B6, B12, and L-Carnitine): A powerful mix that boosts fat metabolism, supports energy levels, and helps your body burn fat more efficiently
Although no data from head-to-head trials comparing retatrutide to other currently approved obesity treatments exist, data from the phase 2 studies with retatrutide suggest that at higher doses, retatrutide could lead to greater WL compared to the most efficacious approved treatments for obesity and T2D such as tirzepatide 15 mg and semaglutide 2.4 mg (Fig